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Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) is tightly linked to at least two lymphoproliferative disorders, primary
effusion lymphoma (PEL) and multicentric Castleman’s disease (MCD). However, the development of KSHV-mediated
lymphoproliferative disease is not fully understood. Here, we generated two recombinant KSHV viruses deleted for the first
RBP-Jk binding site (RTA1st) and all three RBP-Jk binding sites (RTAall) within the RTA promoter. Our results showed that
RTA1st and RTAall recombinant viruses possess increased viral latency and a decreased capability for lytic replication in HEK
293 cells, enhancing colony formation and proliferation of infected cells. Furthermore, recombinant RTA1st and RTAall viruses
showed greater infectivity in human peripheral blood mononuclear cells (PBMCs) relative to wt KSHV. Interestingly, KSHV
BAC36 wt, RTA1st and RTAall recombinant viruses infected both T and B cells and all three viruses efficiently infected T and B
cells in a time-dependent manner early after infection. Also, the capability of both RTA1st and RTAall recombinant viruses to
infect CD19+ B cells was significantly enhanced. Surprisingly, RTA1st and RTAall recombinant viruses showed greater
infectivity for CD3+ T cells up to 7 days. Furthermore, studies in Telomerase-immortalized human umbilical vein endothelial
(TIVE) cells infected with KSHV corroborated our data that RTA1st and RTAall recombinant viruses have enhanced ability to
persist in latently infected cells with increased proliferation. These recombinant viruses now provide a model to explore
early stages of primary infection in human PBMCs and development of KSHV-associated lymphoproliferative diseases.
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Introduction
Kaposi sarcoma-associated herpesvirus (KSHV, also known as
human herpesvirus 8 [HHV8]) infection is pivotal to the
development of Kaposi sarcoma (KS). KSHV is also strongly
associated with two lymphoproliferative diseases, primary effusion
lymphoma (PEL) and Multicentric Castleman’s disease (MCD)
[1,2]. During its lifespan, KSHV undergoes latent and lytic cycle
replication (reactivation). In comparison to lytic cycle replication,
fewer genes are expressed in latent infection and a number of these
genes are involved in disruption of the cell cycle, and in
maintenance of the viral genome. One of those latent genes is
Latency-associated nuclear antigen (LANA), encoded by KSHV
open reading frame 73 (ORF73), which is critical for persistence of
the viral episome and maintenance of latent infection in KSHV
infected cells [3]. During lytic cycle replication, almost all viral
genes are expressed in a staged temporal manner. The replication
and transcription activator (RTA) is encoded by KSHV ORF50
and plays an essential role in the control of the lytic replication
cycle. RTA can activate KSHV lytic genes including ORF6
(single-stranded DNA-binding, SSB), ORF21 (thymidine kinase,
TS), ORF57 (mRNA transcript accumulation. MTA), ORF59
(polymerase processivity factor, PF-8), ORF 74 (vGPCR), K2
(vIL-6), K5 (MIR-2), K6 (vMIP-1), K8 (k-bZIP), K9 (vIRF), K12
(kaposin), K14(vOX-2) and polyadenylated nuclear (PAN)
through direct binding with high affinity to RTA-responsive
elements (RREs) or in combination with cellular trans-
cription factors, RBP-Jk, Ap-1, C/EBP-a, Oct-1, and Sp1
[4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22]. Recombi-
nant viruses that lack RTA establish latency quite efficiently but
are unable to reactivate [23]. Our earlier studies also suggest that
RTA contributes to the establishment of KSHV latency by
activating LANA expression during the early stages of infection
through the major effector of the Notch signaling pathway,
recombination signal binding protein Jk (RBP-Jk). This mutual
RTA/LANA feedback regulatory mechanism is likely to be a key
event in establishment of KSHV latency and is yet to be
completely elucidated.
RBP-Jk, also named CBF1 or CSL, is a member of the CSL
family (CBF1, Suppressor of Hairless, and Lag) and is the major
downstream effector of the Notch signaling pathway [24,25].
RBP-Jk functions on the target gene by recruiting distinct protein
complexes to the promoter. RTA mimics Notch signaling and can
activate target promoters by binding to the repression domain of
RBP-Jk, thereby activating promoters [17]. In KSHV-infected
cells, RBP-Jk mediates cooperative transactivation of KSHV
genes, ORF57, K-bZIP, ORF6 (SSB), K14 (vGPCR), LANA, K8,
ORF47 and RTA [12,15,17,26,27,28,29]. The KSHV RTA
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mutation of the first and third RBP-Jk sites within the KSHV
RTA promoter results in approximately 50% repression of RTA
expression in vitro [30].
Understanding the pathogenesis of specific concerns including
Kaposi’s sarcoma has been aided by development of model
systems [31]. It has been difficult to establish lymphoblastoid cell
lines in culture by KSHV, which has slowed the understanding of
the natural mechanism of KSHV-mediated lymphoproliferative
disease. However, the mechanism of differentiation and prolifer-
ation due to EBV infection in B lymphocytes are well documented
[32]. Recently, two groups have shown that KSHV infects a sub-
set of tonsillar B cells driving plasmablast differentiation and
proliferation, and KSHV-encoded viral FLICE-inhibitory protein
(vFLIP) induces B lymphocytes transdifferentiation and tumori-
genesis in an animal model [33,34]. Furthermore, Myoung and
Ganem reported that T and B lymphocytes in primary human
tonsils can be infected by KSHV, with B lymphocytes producing a
substantial amount of infectious virions [35,36]. In contrast to
EBV, transformation and immortalization have not been clearly
observed in KSHV infected B or T cells. KSHV infection of
peripheral blood mononuclear cells (PBMCs) occurs prior to the
onset of KS [37], and KSHV DNA is frequently detected in
immune-deficient patients [38,39,40,41]. In addition, PBMCs of
KSHV infected marmosets support viral infection and replication
[42]. Finally, we recently showed that PBMCs exposed to virions
from BAC36-293 cells can effectively model early infection [43].
Our previous studies showed that mutation of the RTA
promoter in vitro (first and all three RBP-Jk binding sites) led to
significant decreases in RTA activity [30]. RTA is an immediate
early protein that serves as the master switch for viral lytic
replication. The interaction between RTA and RBP-Jk controls
the activation of multiple viral target genes which are absolutely
critical for virus reactivation [17,26,27]. Based on these observa-
tions, we generated two subtly mutated recombinant KSHV
viruses based on BAC36 (wt), RTA1st (deletion of the first RBP-Jk
binding site in the RTA promoter), and RTAall (deletion of all
three RBP-Jk binding sites in the RTA promoter). Our results
show that RTA1st and RTAall recombinant viruses had enhanced
ability to maintain viral latency and decreased capability to drive
lytic replication in infected cells. This resulted in an increase in
cell growth and proliferation. Furthermore, RTA1st and RTAall
recombinant viruses were enhanced in their ability to infect
human PBMCs. Both recombinant viruses infected T and B cells
during primary infection, resulting in increased infectivity during
the early stage of infection. Long-term persistence of the viral
episome in infected cells further confirmed that RTA1st and
RTAall recombinant viruses had a greater ability to maintain
latent infection and enhanced proliferation. Our study provides




Human embryonic kidney 293 (HEK 293) cells were main-
tained in Dulbecco’s modified Eagle medium (DMEM) supple-
mented with 5% bovine growth serum. De-indentified Human
peripheral blood mononuclear cells (PBMCs) were obtained from
the University of Pennsylvania CFAR Immunology Core. The
Core maintains an IRB approved protocol in which Declaration of
Helsinki protocols were followed and each donor gave written,
informed consent. Telomerase-immortalized human umbilical
vein endothelial (TIVE) cells were a kind gift from Dr. Rolf
Renne [44]. The wild-type KSHV BACmid, BAC36 wt, was
provided by S. J. Gao (University of Texas, San Antonio, TX).
Kanamycin (Kn) cassette containing plasmid, pL452 was obtained
from the National Cancer Institute Biological Resources Branch.
Construction of KSHV mutants with in RTA promoter,
BAC36-RTA1st and BAC36 RTAall within the RTA promoter
Mutagenesis of BAC36 was performed using the Red
Recombination method as described previously [45]. The primers
used were BAC 36-RTA1st, the forward PCR primer 59- caaaa-
ctgtgtttagtagcaacacaccctggcgagcccagctgtcgaggcCAATTCCGAT-
CATATTCAATAACCCTTAAT -39 (target sequence is low-
cased), and the reverse primer, 59- tttgagaagcatctttagagagcta-
gaggcttccgtccccaatttcagtaAGAACTAGTGGATCCCCTCGAG-
GGACCTA -39 were used to amplify a Kan resistance cassette
(underlined sequence is Kan cassette primer) flanked by BAC
sequences (genomic position 69057 and 69171, NC_009333);
BAC 36-RTAall, the forward PCR primer 59- caaaactgtgtttagtag-
caacacaccctggcgagcccagctgtcgaggcCAATTCCGATCATATTC-
AATAACCCTTAAT -39 (target sequence is low-cased), and the
reverse primer, 59- atggcgacgtgcactactcgggacccccgcgcaccccggca-
tatggagtaAGAACTAGTGGATCCCCTCGAGGGACCTA -39
were used to amplify a Kan resistance cassette (low-cased sequence
is Kan cassette primer) flanked by BAC sequences (genomic
position 69057 and 70417, NC_009333). The Kan cassette flanked
with 50bp KSHV genomic sequence was electroporated into
EL350 containing BAC36 at 1.75kV, and the resulting colonies
plated on Kanamycin (50 mg/ml) and chloramphenicol (25 mg/
ml) double selection plates followed by incubation at 30uC. BAC
plasmid DNA was isolated from 10-ml overnight cultures by the
alkaline lysis procedure and characterized by restriction enzyme
analysis followed by Southern blot analysis. The transformed
single colonies were induced with 10% L (+) arabinose (Sigma-
Aldrich, Inc., St. Louis, MO) for 1h, then plated to Chloram-
phenicol and Kanamycin selection plates, separately. The
resulting single colonies on Chloramphenicol plates were inocu-
lated in 10-ml of LB with chloramphenicol overnight at 30uC.
Small-scale DNA isolation was performed to characterize the
DNA of specific mutants, followed by Southern blot analysis. All
the clones were confirmed by DNA sequencing using the
University of Pennsylvania Perelman School of Medicine sequenc-
ing core. Large preparations of KSHV BAC plasmids were
obtained from 500-ml E. coli cultures with the Qiagen Large
Author Summary
Kaposi’s sarcoma-associated herpesvirus (KSHV) is tightly
linked to at least two lymphoproliferative disorders,
primary effusion lymphoma (PEL) and multicentric Castle-
man’s disease (MCD). The life cycle of KSHV consists of
latent and lytic phase. RTA is the master switch for viral
lytic replication. In this study, we first show that
recombinant viruses deleted for the RBP-Jk sites within
the RTA promoter have a decreased capability for lytic
replication, and thus enhanced colony formation and
proliferation of infected cells. Interestingly, the recombi-
nant viruses show greater infectivity in human peripheral
blood mononuclear cells (PBMCs). The recombinant viruses
also infected CD19+ B cells and CD3+ T cells with increased
efficiency in a time-dependent manner and now provide a
model which can be used to explore the early stages of
primary infection in human PBMCs, as well as the
development of KSHV-associated lymphoproliferative dis-
eases.
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turer instructions.
Southern blot and junction PCR analysis
The DNA probe used for Southern blot hybridizations was
amplified as a 1.4-kb fragment (corresponding to the RBP-Jk locus
of RTA promoter) with the KSHV genome as the template and
primer set forward: 59-ATGCAGCGGGGTGAGCCTGCCTC-
CAGCC-39, and reverse, 59-TTGCAGAATACTGGACAA-
CAGCGCGTCG-39. Purified KSHV BAC plasmid DNA was
digested with XhoI and resolved on 0.65% agarose gels in 0.5X
Tris-borate-EDTA buffer for 14 to 18 h at 40 V. DNA fragments
were visualized by ethidium bromide staining, denatured, and
transferred to Zeta-Probe GT genomic tested blotting membranes
(Bio-Rad Inc, Hercules, CA). DNA probes were radiolabeled with
[a-
32P] dCTP with the NEBlot (New England Biolabs, Inc.,
Ipswich, MA). Prehybridization was performed at 63uC for 1 h in
hybridization buffer (7% sodium dodecyl sulfate, 10% polyethyl-
ene glycol, 1.5X SSPE [1X SSPE is 0.18 M NaCl, 10 mM
NaPO4, and 1 mM EDTA, pH 7.7]). DNA blots were hybridized
with radiolabeled probes in the same solution at 63uC for about
7 h. Blots were washed twice for 15 min with 2X SSC (1x SSC is
0.15 M NaCl plus 0.015 M sodium citrate)-0.1% sodium dodecyl
sulfate and twice for 30 min with 0.1X SSC-0.1% sodium dodecyl
sulfate at 63uC. Blots were exposed to a Phosphoimager plate
(Molecular Dynamics, Inc. Sunnyvale, CA) overnight at room
temperature followed by scanning with the Typhoon 9200 (GE
Healthcare Inc., Piscataway, NJ).
Junction PCRs were performed to identify the expected
deletions. The primers used were RTA1st (genomic position
69010 to 69291, NC_009333) 59 TCCCAGCCAAGTCCCTC-
GTG 39 and 59 GTCCCACTGCTGCGATCCAG 39; RTAall,
(genomic position 69010 to 70537, NC_009333) 59 TCCCAGC-
CAAGTCCCTCGTG 39 and 59 GCCCGGATACGCGCA-
CATGC 39.
Reconstitution of recombinant viruses, virus induction
and determination of virus copies
Purified Bac36 DNAs were transfected into 293 cells via CaPO4
method. Hygromycin B (150 ng/ml) was then added for selection
24 h after transfection. Three weeks after selection, homogenous
populations of GFP-positive cells harboring KSHV Bac36 DNAs
were obtained. Butyric Acid at a final concentration of 3 mM and
TPA (Sigma) at 20 ng/ml was used for lytic induction. Cell
suspensions were centrifuged at 3000 rpm for 20 min and the
supernatant was filtered through a 0.45 mm cellulose acetate filter.
The viral particles were concentrated by ultracentrifugation at
70,000xg at 4uC and stored at 280uC.
Infection of PBMCs and TIVE cells with recombinant KSHV
virions
Infection of PBMCs were performed as described previously
[43]. In brief, 1x107 were infected by incubation with virus
suspension in 1ml of RPMI 1640 (with 10% FBS) medium in the
presence of Polybrene at a final concentration 5 ng/ml (Sigma,
Marborough, MA) and incubated for 4 h in 37uC. Cells were
centrifuged for 5min at 1500rpm, the supernatant discarded,
pelleted cells were washed by fresh RPMI medium for 2 times and
resuspended in fresh RPMI 1640 (10% FBS) medium in 6-well
plates and culture at 5% CO2, 37uC humidified incubator.
TIVE cells were cultured in 12-well plates to 60% confluence in
Medium 199 supplemented with 20% FBS, 200 mM L-glutamine,
5 mg/ml Penicillin/Streptomycin(P/S) and 10 mg/ml Endothelial
cell growth supplement from bovine neural tissue. Concentrated
viruses were added to the supernatant in the presence of Polybrene
(4 mg/ml) and spun at 2,500 rpm for 1 h at room temperature. The
supernatants were removed and washed twice and then incubated
with fresh medium. GFP expression was used to monitor infection
under fluorescence microscope (Olympus Inc., Melville, NY).
Extraction and determination of intracellular and
extracellular viral DNAs
For quantitation of intracellular viral DNA, cells were harvested
and washed twice with 1xPBS to remove the residual viruses. Cells
were incubated by HMW buffer (10mM Tris-HCl pH 8.0,
150mM NaCl, 10mM EDTA, 0.5% SDS) for 2 hrs at 55uC.
0.5 mg/ml proteinase K was added and incubated at 37uC
overnight with subsequent extraction in phenol/chloroform/
isopropanol. Viral DNA was treated with RNase, then precipitated
and resuspended in water. Extracellular viral DNA was extracted
from culture supernatants as essentially described previously
[35,43]. In brief, virions were pelleted down at 70,000xg for 2
hrs at 4uC and resuspended. Cellular DNAs and free viral DNAs
were removed by treatment with DNase I at 37uC for 1,2 hrs.
Virion DNA was treated with HMW buffer for 20 minutes.
Lysates were treated with proteinase K overnight at 37uC with
subsequent extraction with phenol/chloroform/isopropanol. In-
tracellular and extracellular viral DNAs were quantitated by real-
time DNA PCR for TR (59 GGCTCCCCCAAACAGGCTCA 39,
and 59 GGGGGACCCCGGGCAGCGAG 39). GAPDH and
BAC36 DNAs were the standards for intracellular and extracel-
lular viral DNAs, respectively.
Quantitation of KSHV RNA
Total RNA from infected PBMCs were extracted by using
TRIzol (Invitrogen, Inc., Carlsbad, CA) and 1 mg DNase-treated
total RNA were used to generate cDNA using the High capacity
RNA-to-cDNA kit (Applied Biosystems Inc., Foster City, CA)
accordingto manufacturer’s instructions. RT-qPCR was performed
onaStepOnePlusReal-TimePCRSystem(AppliedBiosystemsInc,
Carlsbad, CA) or Opticon 2 Real-Time PCRSystem. The reactions
were carried out in a 96-well plate at 95uC for 10 min, followed by
35 cycles at 95uC for 30 s, 51uC for 30 s and then 72uC for 40 s.
The differences of cycle threshold values (CT) between the samples
(DCT) were calculated after standardization by GAPDH and
converted to fold changes using one of the samples as a standard (1-
fold). The primers used were LANA: 59 CATACGAACTC-
CAGGTCTGTG 39,5 9 GGTGGAAGAGCCCATAATCT 39;
RTA: 59 CAGACGGTGTCAGTCAAGGC 39,5 9 ACATGA-
CGTCAGGAAAGAGC 39; GAPDH 59 GGTCTACATGGCA-
ACTGT GA 39,5 9 ACGACCACTTTGTCAAGCTC 39. All the
reactions were run in triplicates.
Immunostaining
Cells were applied to a slide well and fixed with 4%
paraformaldehyde with 0.1% Triton X-100, and blocked with
10% BSA. Cells were then incubated with a primary antibody
(Mouse anti-LANA), and specific signals were detected with a
secondary antibody conjugated with Alexa Fluor 594 (Invitrogen,
Carlsbad,CA).Thecellswerecounterstained with 49,69-diamidino-
2-phenylindole (DAPI). Images were observed and recorded with a
Fluoview FV300 microscope (Olympus Inc., Melville, NY).
Colony formation and growth assay
BAC36 wt, BAC RTA1st and BAC RTAall transfected 293
cells were selected for 3-4 weeks with Hygromycin B. 300 stably
Enhanced KSHV Latent Infection and Proliferation
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supplemented with 10% FBS, Hygromycin B (150 ng/ml) and
Difco Noble Agar (BD, Franklin Lakes, NJ) (0.5%). After 2 weeks
of growth, the colony were monitored and photographed under
fluorescence microscope (Olympus Inc., Melville, NY). The plates
were scanned by Typhoon 9200 for GFP signals and the colony
number was quantitated using the Odyssey V3.0 software.
Flow cytometry
BAC36 wt, BAC RTA1st and BAC RTAall stably transfected
293 cells were harvested and fixed in 1% paraformaldehyde for
30–60 min. The fixed cells were washed twice by 1XPBS and
analyzed using on FACSCalibur based on GFP signals.
Infected PBMCs cells were stained essentially as described
previously [46,47]. Briefly, PBMCs were harvested and washed at
1dpi, 2dpi, 4dpi and 7dpi. T cells and B cells were detected by
using the APC conjugated anti-CD3 and PercpCy 5.5 conjugated
anti-CD19 mAbs (BD Biosciences, San Jose, CA). GFP signals
were used to monitor KSHV positive cells. Data were acquired on
FACSCalibur equipped with CellQuest Pro software and analyzed
using FlowJo software.
Statistics
Data are shown as mean values with standard errors of the
means (SEM). The significance of differences in the mean values
was evaluated by 2-tailed Student’s t test. P,0.05 was considered
statistically significant.
Results
Generation of recombinant KSHV viruses deleted for RBP-
Jk binding sites within the RTA promoter (RTA1st and
RTAall)
Our previous studies showed that RTA contributes to
establishment of KSHV latency by activating LANA expression
during the early stages of infection via RBP-Jk, the major effector
of the Notch signaling pathway [28]. The activity of the RTA
promoter was reduced about 40% in the truncations of first RBP-
Jk and all three RBP-Jk binding site within RTA promoter
compared to the wt promoter [30]. To investigate the roles of the
RBP-Jk binding sites in the RTA promoter, we constructed two
KSHV recombinant viruses, BAC RTA1st with a deletion of the
first RBP-Jk binding site and RTAall with deletion of all three
RBP-Jk binding sites. BAC36 wt carries the full KSHV genome, a
GFP tag, and a eukaryotic resistance gene, hygromycin [48].
Infectious KSHV can be reconstituted by transfection of BAC36
wt DNA into 293 cells [48]. Using the BAC36 wt as a template, we
designed PCR primers so that the RBP-Jk binding sites in the
RTA promoter were removed from the genome. Fig. 1A and B
shows a schematic for the generation of the recombinant BAC
RTA1st and RTAall using PCR primers that integrated the
Kanamycin resistance gene (Neo: the neo cassette is resistant to
Neomycin or Kanamycin in prokaryotes) and two loxP sites from
plasmid pL452 into the BAC36 genome, replacing the RBP-Jk
binding sites of the RTA promoter. LoxP is the substrate sequence
of Cre recombinase, so the insert fragment between two loxP sites
(including neo cassette) can be subsequently removed by
expressing Cre recombinase after induction by L-arabinose [49].
A PCR product containing Neo
r flanked by loxP sites and two
fragments of 50-bp KSHV sequences from the two ends of the
RBP-Jk site in the RTA promoter was generated using pL452
plasmid as a template. This PCR product was transfected into
BAC36 wt-E.coli 350 to remove the RBP-Jk site in the RTA
promoter after homologous recombination and Cre-mediated
excision of Neo
r. The resulting BAC recombinants were screened
and analyzed on 0.65% agarose and subsequently by southern blot
analysis to show that the RBP-Jk binding site in the RTA
promoter was removed from the KSHV genome (Fig. 1A and C).
Digestion of the BAC36 wt DNA with XhoI generated one
12584kb fragment at the RBP-Jk binding site in the RTA
promoter. For BAC RTA1st, replacement of the RBP-Jk binding
site with the Kan cassette changes the two fragment sizes to
9486bp and 4973bp. After induction, the fragment between two
loxP sites was removed, so the smaller fragment (4973b) shifted in
size to 3176kb, indicating removal of Kan cassette. Southern blot
showed the presence of a 5kb band before induction and a unique
3kb band in recombinant BAC RTA1st when hybridized with a
probe within the RBP-Jk binding site (Fig. 1A and C). To further
confirm whether the altered digestion pattern of the BAC mutants
was the result of the expected recombination, we carried out
junction PCR by using the primers designed at the recombination
site showing that the junction bands in the BAC RTA1st shifted
based on the presence of the remaining loxP site and XhoI site
(Fig. 1D). Similarly, For BAC RTAall, replacement of the RBP-Jk
binding sites with the Kanamycin cassette changes the two
fragment sizes to 8240bp and 4973bp. After induction, the
fragment between two loxP sites was removed, so the smaller
fragment (4972b) shifted in size to 3176kb - indicating removal of
the Kan cassette. Southern blot showed the presence of a 5kb band
before induction and a unique 3kb band in the recombinant BAC
RTAall when hybridized with a probe within the RBP-Jk binding
site (Fig. 1B and E). Junction PCR showed that the junction bands
in the BAC RTAall shifted based on the presence of the remaining
loxP site and XhoI site (Fig. 1F). Finally, the PCR products were
sequenced to confirm the expected mutation.
BAC RTA1st and RTAall recombinant KSHV stable 293 cells
had a decreased capability for lytic replication
To reconstitute recombinant viruses, we transfected BAC36 wt,
RTA1st and RTAall DNAs into 293 cells. The transfection
efficiencies were monitored by the fluorescence microscopy. GFP
positive cells were detected after 24–48h post-transfection (data
not shown). Positive cells were enriched by hygromycin selection,
generating 293 cell lines bearing BAC36 wt, RTA1st and RTAall
(Fig. 2A). Subsequently, the cells were fixed and immunostained
against LANA to confirm that BAC 36 wt and RTA1st and RTAall
stable cell lines harbored the KSHV genome (Fig. 2B). Similar
levels of GFP positive signals and LANA staining were observed
for all three stably transfected cell lines generated due to
hygromycin selection.
To ensure that both RTA1st and RTAall stable cells were able to
produce recombinant viruses after lytic reactivation, the cells were
treated with TPA and butyric acid to induce lytic reactivation.
Whole cell lysates were prepared from the uninduced and induced
cells at 24, 48, 72 hours post induction (hpi), and the expression of
LANA and RTA were analyzed by western blot analysis using the
corresponding specific antibodies. The results showed that LANA
expression exhibits a slight decrease after induction in BAC36 wt-
293 cells at 48 and 72 hpi as more cells switch to lytic replication.
However, there was no obvious difference in RTA1st and RTAall-
293 cells (Fig. 3A). This may be due to the fact that more cells were
infected with RBP-Jk mutant viruses in latent phase with higher
levels of LANA. In the wild type, RTA expression was not affected
thus most of the viral genome copies underwent lytic reactivation
thereby expression of latent protein, LANA diminished over time.
This is further evident by the levels of RTA, which increased, in a
time dependent manner after induction with TPA and butyric
acid, in wt BAC36-293 cells (Fig. 3A). Notably, though RTA
Enhanced KSHV Latent Infection and Proliferation
PLoS Pathogens | www.plospathogens.org 4 January 2012 | Volume 8 | Issue 1 | e1002479Figure 1. Generation of two recombinant KSHV BACmids with deletion of RBP-Jk sites in the RTA promoter. (A) Schematic diagram
showing generation of BAC RTA1st, a recombinant BAC36 with first RBP-Jk site deletion in the RTA promoter (B) Schematic diagram showing
generation of BAC RTAall, a recombinant BAC 36 with deletion of first, 2
nd and 3
rd RBP-Jk site in the RTA promoter. (C) Ethidium bromide-stained gel
and southern blots with BAC36 wt (lane 1) and the mutated BACmid, RTA1st (Unfloxed, lane 2) and RTA1st (floxed, lane 3), cleaved with XhoI. (D) PCR
analysis for Bac36 wt and RTA1st recombinant virus at the junction of deletion of RBP-Jk site within RTA promoter. (E) Ethidium bromide-stained gel
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induction in all cell lines, the levels of RTA expression in RTA1st
and RTAall-293 was much lower than seen in BAC36 wt-293 cells.
This suggests that RTA expression was reduced in RTA1st and
RTAall-293 cells (Fig. 3A). In addition, the viruses were collected
from supernatant of the induced BAC36 wt, RTA1st and RTAall-
293 cells and quantitated for virion particles by quantitative PCR
analysis. The results showed that RTA1st and RTAall-293 cells
produced fewer KSHV genomes, suggesting a decrease in virion
production post-induction (Fig. 3B). This confirms our hypothesis
that deletion of the RBP-Jk binding sites in the RTA promoter of
KSHV results in an attenuated lytic cycle and thus decreased viral
progeny. Furthermore, total DNA was extracted from BAC36 wt,
RTA1st and RTAall-293 cells. Intracellular viral DNA levels were
determined by quantitative PCR analysis standardized by
GAPDH. The result showed that RTA1st and RTAall-293 cells
had a greater number of viral copies compared to BAC36 wt-293
cells, further indicating that RTA1st and RTAall deficient viruses
exhibited a decrease in lytic capability although the genome copy
numbers were greater (Fig. 3C).
RTA1st and RTAall recombinant KSHV showed enhanced
latency and promoted cell growth and proliferation of
293 cells
BAC36 wt, RTA1st and RTAall are recombinant KSHV viruses
harboring a GFP marker which allows us to track viral genome
stability in 293 cells. Furthermore, RTA1st and RTAall 293 cells
possessed higher intracellular viral DNA copies than BAC36 wt-
293 cells. We postulated that both of them should have increased
GFP signals. Flow cytometry was performed based on GFP signals
for BAC36 wt, RTA1st and RTAall -293 cells. Interestingly,
RTA1st and RTAall-293 cells showed approximately 78% and
93% GFP fluorescence intensity, respectively. However, only 41%
GFP fluorescence intensity was seen for BAC36 wt-293 cells
(Fig 4A, B) and pellets from collected RTA1st and RTAall-293 cells
also had a more intense green color based on visual inspection
when compared to BAC36 wt-293 cells (data not shown).
KSHV is a known human oncovirus and is associated with
cellular transformation [31,50,51]. Therefore we wanted to
determine the proliferation rate for BAC36 wt, RTA1st and
RTAall-293 cells. Cells were starved in DMEM with 0.1% FBS
overnight. Next day, media were replaced with DMEM
supplemented with 5% FBS. Cells were cultured for 24 hrs and
harvested for analysis by flow cytometer. Interestingly, RTA1st and
RTAall-293 cells had a higher percentage of cells (55.7% and
59.4%) comparing to BAC36 wt-293 (51.8%) in G1 phase which
was consistant after multiple repeats (Fig. 4C). These results
suggested that RTA1st and RTAall recombinant viruses can
promote cell growth and proliferation in the infected cells. In
addition, cells harboring more viral genome copies should have an
enhanced capability for driving cell growth. Therefore we tested
this hypothesis with a colony formation assay. The colonies were
photographed using fluorescence microscopy and scanned by a
Typhoon 9200 system based on GFP signals. Surprisingly, the
average size of hygromycin-resistant colonies for RTA1st and
RTAall-293 cells was distinctively bigger (almost double) relative to
BAC36 wt-293 cells (Fig. 4D), indicating that RTA1st and RTAall
recombinant viruses possess enhanced capability for cell growth.
Furthermore, GFP positive colonies were scanned and quantitat-
ed. The results also showed that RTA1st and RTAall-293 cells
showed a 1.8 and 2.4 fold increase in total colonies in comparison
to BAC36 wt-293 (Fig. 4E, F), providing further evidence that
mutation of the RBP-Jk sites enhanced KSHV latent infection and
so promoted cell growth and proliferation.
RTA1st and RTAall recombinant viruses have enhanced
latent infection in human peripheral blood mononuclear
cells (PBMCs)
KSHV infection is strongly linked to two lymphoproliferative
diseases, referred to as PEL and MCD [1,2]. Infection of PBMCs
with KSHV can provide greater insights into initiation and
development of KSHV associated lymphomagenesis. KSHV can
infect many cell types, including epithelial cells, keratinocytes,
endothelial cells and PBMCs which are permissive cells with
varying degrees of infectivity [36,44,52]. Previous studies show
that determination of GFP signals can be effectively used to
monitor the efficiency by which KSHV BAC36 infects PBMCs
[43]. Our investigation shows that mutations of the RTA
promoter, specifically the RBP-Jk cognate sequences, results in
reduced RTA expression as well as reduced RTA-mediated auto-
activation of its promoter [30]. Here, we have now developed a
BAC system to further explore the feedback regulation of RTA by
LANA. As described previously, GFP signals were monitored by
green fluorescence from the infected PBMCs [43]. We concen-
trated BAC36 wt, RTA1st and RTAall viruses from TPA and
Butyric acid treated-293 cells. The concentrated viruses were used
to infect PMBCs and the infected cells were monitored at 1, 2, 4
and 7 days post infection (dpi). The expected result was that virion
particles from both BAC36 wt and recombinant viruses would be
detected as GFP signals were seen by 2dpi (Fig. 5A). Infected
PBMCs were collected at 1, 2, 4 and 7dpi and total DNA was
extracted as indicated in materials and methods. Viral DNA levels
were determined by real-time PCR normalized to endogenous
GAPDH. As indicated by GFP signals, viral copies of BAC36 wt
showed a time-dependent manner increase in viral DNA, and the
viral DNA copies of RTA1st and RTAall recombinant viruses had a
similar level at 1 and 2 dpi (Fig. 5B). However, genome copies of
RTA1st and RTAall recombinant viruses showed a significant
increase in infected PBMCs above that of BAC36 wt at 1dpi, 2dpi,
4dpi and 7dpi, suggesting that more latent viral genomes were
tethered to the host genome (Fig. 5B). Extracellular viral DNAs
were collected from infected supernatants and quantitated by
using KSHV TR primer set. In contrast, viral DNA levels of
RTA1st and RTAall recombinant viruses were decreased in
comparison to BAC36 wt from 1dpi to 7dpi, indicating that the
lytic cycle of the recombinant viruses was not as robust. These data
further support our pervious results showing that RTA1st and
RTAall recombinant viruses exhibited an enhanced latent infection
phenotype and a reduced capability for lytic replication in this
system (Fig 5C).
RTA1st and RTAall recombinant viruses have reduced
capability for inducing lytic replication after primary
infection
LANA and RTA are viral encoded molecular switches for latent
and lytic phases in KSHV infection. We wanted to determine the
mRNA levels of RTA and LANA during primary infection.
and southern blots with BAC36 wt (lane 1) and the mutated BACmid, RTAall (Unfloxed, lane 2) and RTAall (floxed, lane 3), cleaved with XhoI. (F) PCR
analysis for BAC36 wt and RTA1st recombinant virus at the junction of deletion of RBP-Jk sites within RTA promoter. DNA fragments were sequenced
and confirmed the mutation.
doi:10.1371/journal.ppat.1002479.g001
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PLoS Pathogens | www.plospathogens.org 6 January 2012 | Volume 8 | Issue 1 | e1002479Figure 2. Transfection of 293 cells with BAC36 wt, BAC RTA1st and BAC RTAall DNAs. (A) Cells were transfected with BAC36 wt, BAC RTA1st
and BAC RTAall DNAs. GFP expression levels were monitored by fluorescent microscopy 2 days after transfection, and the transfected cells were split
and selected with Hygromycin B. The hygromycin-resistant cells were pooled and passed three to four times. The homogenous population of GFP-
positive cells harboring KSHV wild-type and mutant genomes were obtained. (B). Immunofluorescence analysis for LANA in BAC36-293 BAC RTA1st-
293 and BAC RTAall-293 cells.
doi:10.1371/journal.ppat.1002479.g002
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detected in BAC36 wt, RTA1st and RTAall infected PBMCs at 1
dpi, 2 dpi, 4 dpi and 7dpi indicating a successful infection (Fig. 6A).
DNase treated total RNA from infected PBMCs at 1 dpi, 2 dpi, 4
dpi and 7dpi were used to generate cDNA and signals of RTA and
LANA transcripts quantitated by real-time PCR. The results
showed that LANA expression from BAC36 wt infected PBMCs
increased in a time-dependent manner. Furthermore, RTA1st and
RTAall recombinant viruses infected PBMCs showed higher
LANA mRNA expression from 1 dpi to 7dpi, indicating that
deletion of the RBP-Jk cognate sequences within the RTA
promoter can result in greater stringency for latent infection
(Fig. 6B). Additionally, mRNA of RTA was also analyzed and
showed a peak at 2dpi in BAC36 wt and recombinant viruses
(Fig. 6C), perhaps promoting lytic infection at an early stage [47].
However, compared to BAC36 wt, RT-PCR results from RTA
mRNA showed lower levels in RTA1st and RTAall infected
PBMCs from 1 dpi to 7dpi with almost no significant change with
RTAall recombinant virus (Fig. 6C). This suggests that deletion of
the RBP-Jk cognate sequences in the promoter led to a dramatic
loss in the ability of the recombinant viruses to induce lytic cycle
activation, and as a result more tightly maintain latent infection
(Fig 6C). Furthermore, KSHV ORF6 which encodes the single-
stranded DNA (ssDNA) binding protein and is tightly associated
with DNA replication, showed increased expression in RTA1st and
RTAall infected PBMCs compared to BAC36 wt infected PBMCs
(Fig 7A). This suggests that KSHV replication is actively engaged
although latent infection is more stringent (Fig 7A). ORF49
encoded by KSHV lies adjacent to and is transcribed in the
opposite orientation to RTA. It also co-operates with RTA to
activate KSHV lytic cycle [53]. We also monitored the activity of
ORF49, which cooperates with RTA during lytic replication
through activation of several lytic promoters containing AP-1 sites
[53]. The mRNA level was initially higher for recombinant viruses
at 1dpi (Fig 7B). However, at 4dpi and 7dpi, the ORF49 transcript
levels for the recombinants were much lower than BAC36 wt with
RTAall greater than 2-fold less at 4dpi. By 7dpi, both RTA1st and
RTAall were further depressed compared to BAC36 wt to about 3-
fold (Fig. 7B). This suggests that active lytic replication of KSHV
was dramatically reduced by 7dpi with a greater propensity for
Figure 3. Comparisons of effect on deletion of RBP-Jk sites within RTA promoter in KSHV lytic life cycle. (A) Comparison of levels of viral
gene expression of BAC36 wt, RTA1st and RTAall recombinant viruses in 293 cells. Western blot for RTA and LANA at 0, 24, 48, 72 hours lytic induction
of BAC36 wt, RTA1st and RTAall stable 293 cell lines in the presence of Butyrate acid and TPA. The same blot was also reprobed with anti-GAPDH
antibody to ensure equal loading of each sample. RD: relative density. (B) Detection of intracellular KSHV viral genome copies using TR primer in
BAC36 wt-293, RTA1st-293 and RTAall-293 cells induced by Butyrate acid and TPA. (C) Detection of extracellular KSHV progeny virion production using
TR primer in the supernatant of BAC36 wt-293, RTA1st-293 and RTAall-293 induced by Butyrate acid and TPA. *P,0.05;* * P,0.01; ***P,0.001 by
Student’s t test.
doi:10.1371/journal.ppat.1002479.g003
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K9 transcript levels. The early lytic protein K8 [54], showed a
general increase in transcript levels over the 7 day period.
However, the levels of K8 transcripts for RTA1st and RTAall were
generally lower than that of the BAC36 wt virus (Fig 7C).
Interestingly, ORF K9 which encodes for vIRF, a homolog to
members of the interferon (IFN) regulatory factor (IRF) and
important for regulating intracellular interferon signal transduc-
tion [55], increased dramatically by 2 days, with BAC36 wt
continuing to increase in K9 transcript levels. At 7 days all viruses
showed a drastic reduction in K9 transcript levels (Fig. 7D). These
results suggest a level of regulation of these transcripts which is
important for controlling latent infection in KSHV.
RTA1st and RTAall recombinant viruses showed enhanced
ability to infect T and B cells during primary infection
Human PBMCs contains lymphoid cells consisting of both T
and B cells. The results above showed that RTA1st and RTAall
recombinant viruses have an enhanced propensity for latent
infection during the early stages of in vitro infection. Recently,
Myoung and Ganem showed that 20–40% T and 4%–5% B cells
from human tonsillar cultures can be infected [36]. However, only
B cells support viral replication and produce progeny. Here, we
are interested in the ability of KSHV to infect T and B cells from
PBMCs during early infection. APC–conjugated anti-CD3 and
PercpCy 5.5-conjugated anti-CD19 mAbs were used to detect
infected T and B cells, respectively. GFP signals were used to
detect KSHV-positive cells. Our results showed that GFP positive
T cells were detected as early as 1 dpi (Fig 8A). The GFP positive
T cells infected by BAC36 wt virus was slightly changed relative to
RTA1st and RTAall recombinant viruses. At 2 dpi, the proportion
of GFP+ CD3+ T cells was 1.65%, 1.86% and 1.64%,
respectively. The percentage of GFP+ CD3+ T cells infected by
BAC36 wt, RTA1st and RTAall recombinant viruses were
increased to 1.68%, 3.32% and 3.7% at 4 dpi, respectively. At 7
dpi, T cells were infected continuously in a time-dependent
manner and the proportion of GFP+ CD3+ T cells were 3.98%
and 4.48% for RTA1st and RTAall relative to 2.04% for BAC36 wt
(Fig 8A). These results further confirms that T cells were infected
and that mutation of RBP-Jk sites within RTA promoter can result
in an increase in T cell infection as determined by GFP signals.
We then investigated the response of B cells exposed to KSHV.
At 1 dpi the percentage of GFP+ CD19+ B cells were 0.48% for
BAC36 wt, 0.72% for RTA1st and 0.79% RTAall recombinant
viruses (Fig 8B). The next day, the proportion of GFP+ CD19+ B
cells increased to 1.77% for BAC36 wt, 1.75% for RTA1st and
1.74 % RTAall. At 4 dpi, the percentage of GFP+ CD19+ B cells
further increased to 2.03% for BAC36 wt, 2.49% for RTA1st and
2.51% RTAall, and at 7dpi, the GFP+ CD19+ B was similar to
that at 4dpi suggesting that little or no further increase in B cell
infection was seen. Furthermore, RTA1st and RTAall recombinant
viruses infected B cells (2.13% and 2.47%) show a consistently
higher rate of infection compared to BAC36 wt infected B cells
(2.05%) (Fig 8B). This suggests that PBMCs were continually
infected over the 7day period. Interestingly, GFP+ CD3+ T cells
had a higher rate of infection compared to GFP+ CD19+ B cells
from the BAC36 wt infected PBMCs (Fig 8C). Importantly,
RTA1st and RTAall recombinant viruses possessed a higher
infectivity compared to BAC36 wt virus for both infected T and
B cells (Fig 8D). The overall amount of the GFP positive cells
showed a definite increase in a time-dependent manner (Fig 8E).
This further supports our previous data showing increased
fluorescent signal from 2dpi to 7dpi. In general when compared
to BAC36 wt, RTA1st and RTAall recombinant viruses infected
PBMCs showed more GFP-positive cells, suggesting an increased
ability for infection and maintenance of the KSHV genome within
the first 7days after infection (Fig 8E).
RTA1st and RTAall recombinant viruses showed an
increased capability for infection and proliferation in
long-term-infected telomerase-immortalized endothelial
cells
Typically, infected PBMCs stopped clumping and most cells
begin to die after 7 dpi. In our experiments, no transformation
and/or immortalization was observed in infected PBMCs in vitro
during the 7-day period. Thus it was difficult to monitor the effect
of long-term infection of RTA1st and RTAall recombinant viruses.
Here, we used recently developed telomerase-immortalized
endothelial cells (TIVE) to monitor the ability of RTA1st and
RTAall recombinant viruses to infect TIVE cells [44]. TIVE cells
were infected with BAC36 wt, RTA1st and RTAall recombinant
viruses as indicated in the materials and methods. GFP signals
confirmed latent infection by BAC36 wt, RTA1st and RTAall
viruses and photographs were taken at 1 week post-infection (wpi),
2wpi and 4wpi (Fig. 9A). We determined the copy number of
KSHV genomes in infected TIVE as a measure of the persistence
of the genomes. Total DNAs were extracted from BAC36 wt,
RTA1st and RTAall recombinant viruses infected TIVE cells at 1,
2, 4wpi. Intracellular viral DNAs were determined by a
quantitative PCR analysis standardized by GAPDH. The result
showed that copy numbers of BAC36 wt, RTA1st and RTAall
recombinant viruses were a slightly lower at 4wpi compared to 1
and 2wpi suggesting a possible loss of KSHV genome due to
genome tethering instability. This phenomenon was also seen in
BCBL-1-derived cell-free virus infected TIVE cells [44]. However,
RTA1st and RTAall recombinant viruses maintained a similar copy
number in the infected TIVE cells and infection levels were
consistently greater than the BAC36 wt infected TIVE cells at 1 to
4wpi (Fig. 9B). These results further indicated that RTA1st and
RTAall recombinant viruses exhibited a decrease in lytic
capability. Previous studies showed that KSHV long-term-infected
telomerase-immortalized endothelial cells exhibit a significant
increase in number of cells in the S phase [44]. Here, we cultured
infected TIVE cells for 4 weeks, harvested, fixed and stained them
with propidium iodide. Flow cytometry analysis showed that the
RTA1st and RTAall infected TIVE cells had an increased S phase
population (29.4% and 32.1%), relative to BAC36 wt (25%) at
1wpi. Therefore, the recombinant viruses infected cells showed an
enhanced capability to proliferate (Fig 9C). Similar patterns were
seen at 2wpi and 4wpi where RTA1st and RTAall all exhibited
Figure 4. Comparison of cell growth and proliferation for WT, RTA1st and RTAall -293 cells. (A) BAC36 wt, RTA1st and RTAall transfected 293
cells selected for 3–4 weeks were assayed by FACS analysis based on GFP signals. (B) Relative GFP density in the BAC36 wt, BAC RTA1st and BAC RTAall
transformed 293 cells. (C) BAC36 wt, RTA1st and RTAall-293 cells were starved in DMEM with 0.1% FBS for overnight. Next day, media were replaced
with DMEM supplement with 5% FBS. Cells were cultured for 24 hrs and harvested for analysis by flow cytometer. (D) 293 cells transfected with
BAC36 wt, BAC RTA1st and BAC RTAall viruses were selected with Hygromycin for a 4-week selection, cells were seed on the plates. Colony were
monitored and photographed under fluorescence microscopy after growth for two weeks. (E) The plates were scanned by Typhoon 9200 based on
GFP signals. (F) The colony number was quantized using odyssey V 3.0.
doi:10.1371/journal.ppat.1002479.g004
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hypothesis that RTA1st and RTAall recombinant viruses can
increase cell proliferation in TIVE cells.
Discussion
KSHV RTA is an immediate early protein (IE) that initiates
KSHV lytic reactivation from latent infection. It can directly or
indirectly stimulate the transcription of a cluster of lytic genes as a
transcription factor through binding to specific promoter sequenc-
es. RTA is a key regulator for KSHV reactivation because its
expression is sufficient to activate the entire lytic cycle. Therefore
understanding the regulation of RTA is to provide a better clue
related to KSHV infection and tumorigenicity. RTA-deficient
viruses are able to establish latency but are unable to reactivate
[23]. Here, in an effort to explore KSHV latency and reactivation
we generated two recombinant viruses which possess different
latency and reactivation profiles compared to BAC36 wt. They
Figure 5. Comparisons of relative infectivity for BAC36 wt, RTA1st and RTAall recombinant viruses. (A) PBMCs were infected by KSHV
BAC36 wt, RTA1st and RTAall viruses with equally loading. GFP expression was monitored under a fluorescent microscope after 2dpi, 4dpi and 7dpi. (B)
Intracellular KSHV viral genome copies were measured by a real-time PCR with primers to TR at 1 dpi, 2 dpi, 4 dpi and 7 dpi. (C) Extracellular KSHV
progeny virion progenies were analyzed by a real-time PCR with primers to TR at 1 dpi, 2 dpi, 4 dpi and 7 dpi. Dpi, days post infection. *P,0.05;
**P,0.01; ***P,0.001 by Student’s t test.
doi:10.1371/journal.ppat.1002479.g005
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stages of KSHV infection. This provides a model with which to
understand the development of KSHV-associated lymphoprolif-
erative diseases.
RTA is an IE protein and its expression is also affected by other
viral or cellular factors. For example, RTA up-regulates its own
expression through interaction with the CCAAT/enhancer
binding protein alpha(C/EBPa) at its promoter [20,56]. Further-
more, RTA can down-regulate its ability for activating specific
viral promoters by cooperating with the viral protein b-Zip, an
early protein encoded by ORF K8 [57,58]. Our previous studies
showed that loss of one of those sites can potentially affect the
Figure 6. Quantitative analysis of KSHV BAC36 wt, RTA1st and BAC RTAall recombinant viruses infected PBMCs at 1dpi, 2dpi, 4dpi
and 7dpi. (A) Immunofluorescence assay for PBMCs infected by KSHV BAC36 wt, RTA1st and RTAall recombinant viruses at 2 dpi, 4 dpi and 7 dpi.
Uninfected and infected PBMCs at 2 dpi, 4 dpi and 7 dpi were stained for LANA protein expression. PBMCs expressed GFP, indicating the presence of
viral genome. (B, C). Quantitative analysis for determination of latent and lytic infection in PMBC cells infected by KSHV BAC36 wt, RTA1st and RTAall
recombinant viruses. Total RNAs were extracted, treated with DNase I, and reverse transcribed to cDNA after 1 dpi, 2 dpi, 4 dpi and 7dpi. Quantitative
Real-time PCR analysis with the primers for LANA and RTA was performed using StepOnePlus Real-Time PCR System. Error bars indicate standard
deviations from three separate experiments.
doi:10.1371/journal.ppat.1002479.g006
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promoter [30]. Importantly, the observation that RTA1st and
RTAall recombinant viruses enhance latency and can promote cell
growth in 293 cells caused us to further investigate these mutations
during early infection.
Many human cancers are associated with tumor viruses [59]
and many are detected in PBMCs. Human papillomavirus (HPV)
DNA has been found as an episomal form in PBMCs, but no
transcripts are detected [60,61]. Recent studies showed that
PBMCs of haematuric cattle are additional reservoir of bovine
papillomavirus type 2 [62]. Though Hepatitis C virus (HCV) is
detected in PBMCs of infected individuals, infected PBMCs are
not observed in co-culture with cell culture systems producing
HCV virions. This implicates additional reservoirs for the virus
and allows for PBMCs infection [63]. However, Polyomavirus BK
(BKV), one of the tumor viruses associated with nephropathy in
renal allografts, elicits a BKV-specific proliferative response in the
PBMCs of healthy individuals and bone marrow transplant
recipients [64,65]. Another human tumor virus, John Cunning-
ham virus (JCV) is detectable in the PMBCs of immunoimpaired
and healthy individuals [66]. The well studied EBV infects B
lymphocytes and induces their differentiation, proliferation [32].
Furthermore, PBMCs infected EBV lead to immortalization and
transformation of B cells [47]. However, the mechanism by which
KSHV infects and transforms B cells is not fully understood. Thus,
the development of lymphoproliferative diseases which include
primary effusion lymphoma and multicentric Castleman’s disease
is yet to be fully understood. Recently, PBMCs from marmosets
orally and intravenously infected with rKSHV.219, showed the
presence of the viral genome and LANA expression [42].
Additionally, T and B cells isolated from primary human tonsillar
cells were shown to be infected by KSHV virions, although more
T cells were infected. However, these infections were abortive
without further lytic infection [35,36]. Other T cells types from
human PBMCs can support KSHV infection [67,68,69]. Similar
patterns were observed showing that both T and B cells from
human PBMCs are effectively infected up to 7 days, suggesting
that KSHV has a different mode of infection compared EBV
infection. Obviously, many more T cells were infected in a time-
dependent manner, perhaps due to the large population of T cells
or a receptor on T cells not highly expressed in B cells. At 4 and 7
dpi, T cells were infected up to 4.48%, over 2 times the percentage
of B cells infected. This phenomenon was also seen in KSHV
infected tonsillar cells, though the life span of infected cells was
Figure 7. Quantitative analysis of ORF 49, ORF6, K8 and K9 expression in KSHV infected PBMCs at 1dpi, 2dpi, 4dpi and 7dpi. Total
RNAs were prepared and transcribed to cDNA and the qRT-PCR analysis with the primers for (A) ORF 49, (B) ORF6, (C) K8 and (D) K9 was performed
using the Power SYBR green PCR master mix with GAPDH as control. Error bars indicate standard deviations from three separate experiments.
doi:10.1371/journal.ppat.1002479.g007
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PLoS Pathogens | www.plospathogens.org 13 January 2012 | Volume 8 | Issue 1 | e1002479Figure 8. FACS analysis of T cells, B cells and GFP-positive cells in BAC36 wt, RTA1st and RTAall recombinant viruses infected PBMCs.
(A, B) KSHV BAC36 wt, RTA1st and RTAall viruses infected PBMCs were harvested at 1dpi, 2dpi, 4dpi and 7dpi. T cells and B cells were detected by using
the APC–conjugated anti-CD3 and PercpCy 5.5 -conjugated anti-CD19 mAbs. GFP signals were monitored KSHV positive cells. Data were acquired on
FACSCalibur equipped with CellQuest Pro software and analyzed using FlowJo software. (C) KSHV infected T cells (CD3+ GFP+). (D) KSHV infected B
cells (CD19+ GFP+). (E) Total KSHV infected PBMC cells (GFP +). *P,0.05;* * P,0.01; ***P,0.001 by Student’s t test (N=9).
doi:10.1371/journal.ppat.1002479.g008
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RTA1st and RTAall recombinant viruses still enhanced population
of T cells in PBMCs, suggesting that infected T cells may be
latently infected. Our data also showed that the percentage of
CD19 + GFP+ B cells was increased from 1dpi to 7dpi.
Unexpectedly, B cell infection boosted the proliferation of infected
cells in a time-dependent manner, though T cells are likely to
suppress lytic replication of infected B cells. It may be the case that
B cells are undergoing lytic cycle replication, releasing progeny
which reinfect both T cells and B cells as there was a general
increase in lytic cycle gene expression within 2dpi. The population
of infected B cells began to decrease at 7dpi, though the number of
infected T cells had peaked. As HIV infection may reduce the
CD4+ T cell counts, KSHV infected T cells may maintain a fine
balance in overall T cell population as well as promote cell
proliferation and immortalization for B cells. Another possibility is
that certain subpopulations of cells were significantly overactive
and may restrict B cell proliferation. Recently, Myoung and
Ganem showed that T cells from infected primary human tonsillar
lymphoid cells by KSHV did not support proper viral transcrip-
tion and did not produce infectious virus. However, activated T
cells may promote or stabilize latency of KSHV infected B cells
[35,36]. Interestingly, we did not see proliferation of B cells but the
percentage of infected B cells was decreased at 7dpi. Therefore we
think other restrictive signals are involved in controlling latency of
infected B cells, and so transformation for B cells was suppressed.
After 7days post-infection, most cells died and no immortalization
was observed. One reasonable explanation is that B cells can
provide same paracrine signal activities to T cells but infected T
cells may lack the ability to receive these signals from B cells, thus
losing their proliferative capability. However, B cells may have a
central role in infection and proliferation of PBMCs. After 7dpi,
the efficiency of infection of B cells was decreased which led to a
dramatic reduction in proliferation of the KSHV infected PBMCs.
Did the presence of more T cells which were continuously infected
destroy the population balance of PBMCs? Do B cells drive
essential signaling important for T cells proliferation? These
questions merit further investigation. In addition, GFP positive
signals showed that more cells were infected in a time-dependent
manner. We ruled out the possibility that TPA may have caused
this effect in infected T and B cells, as a side-by-side comparison
between BAC36 wt, RTA1st and RTAall recombinant viruses
strongly supported our conclusion [70]. We clearly showed that
RTA1st and RTAall viruses infected total GFP-positive B and T
cells showed a prominent increase relative to BAC36 wt in PBMCs
up to 7dpi. These results further support our hypothesis that
mutation of RBP-Jk in the RTA promoter can enhance KSHV
latent infection of both of B and T cells in PBMCs during primary
infection.
The expression of total mRNA from infected PBMCs provides
additional information and further reinforces the pattern of
KSHV infection. RTA1st and RTAall recombinant viruses showed
a decrease in K8 expression, though the down-regulation was not
necessarily as strong as in B cells infected with RTA-deficient virus
[23]. However, this is reasonable because neither RTA1st nor
RTAall recombinant viruses abrogated viral lytic capabilities.
RTA1st and RTAall recombinant viruses up-regulated KSHV
ORF6 (SSB, single-stranded DNA binding protein) indicating that
viral DNA replication is active in infected PBMCs. LANA
expression was also up-regulated, suggesting a more tightly latent
infection due to the action of LANA on RBP-Jk. ORF 49
expression was down-regulated in RTA1st and RTAall recombi-
nant viruses infected PBMCs, suggesting that these recombinant
viruses may in part lose their lytic capability. Interestingly, the
mRNA levels of ORF K8 which is a direct target of RTA [71], was
significantly decreased in RTA1st and RTAall recombinant viruses
infected PBMCs, strongly suggesting that the two recombinant
viruses possess a reduced capability for lytic replication during
primary infection. Overall, these data further supports our
hypothesis that recombinant RTA1st and RTAall viruses are
enhanced in their ability to maintain latency after infection of
primary cells.
Though PBMCs were effectively infected, long-term infection of
B and T cells was not supported. RTA1st and RTAall recombinant
viruses showed on increase in genome copies in long-term-infected
TIVE cells providing evidence that mutation of the RBP-Jk sites
within the RTA promoter enhanced KSHV latent infection and
induces the proliferative capability of the infected primary cells.
In conclusion, we have now experimentally shown that KSHV
recombinant viruses with mutated RBP-Jk sites within the RTA
promoter possess an enhanced ability to maintain latent infection
in transformed-293 cells as well as PBMCs during early infection.
Our studies further confirm and define our previously published
data which showed the effects on truncation of the RTA promoter
and has important implications regarding the development of
KSHV-associated lymphoproliferative disease. These recombinant
viruses now provide a model which can be used to explore the
early stages of primary infection in human PBMCs as well as the
development of KSHV-associated lymphoproliferative diseases.
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